Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwangmin Choi

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cell Chemical Biology|January 7, 2026
Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemiaEmma E Uible, Issac Choi, Courtnee A Clough, et al.
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
Cell Stem Cell|January 19, 2022
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activityTomoya Muto, Maria Guillamot, Jennifer Yeung, et al.
Cell Reports|February 25, 2016
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma InitiationJianqiang Wu, Vincent W Keng, Deanna M Patmore, et al.
Science Translational Medicine|September 6, 2019
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Morgan M Walker, LaQuita M Jones, et al.
Nature Genetics|May 12, 2015
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisBranden S Moriarity, George M Otto, Eric P Rahrmann, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cell Chemical Biology|January 7, 2026
Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemiaEmma E Uible, Issac Choi, Courtnee A Clough, et al.
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
Cell Stem Cell|January 19, 2022
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activityTomoya Muto, Maria Guillamot, Jennifer Yeung, et al.
Cell Reports|February 25, 2016
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma InitiationJianqiang Wu, Vincent W Keng, Deanna M Patmore, et al.
Science Translational Medicine|September 6, 2019
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Morgan M Walker, LaQuita M Jones, et al.
Nature Genetics|May 12, 2015
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisBranden S Moriarity, George M Otto, Eric P Rahrmann, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Pageof 8